DE69227767T2 - Partielle Flüssigkeitsbeatmung mittels Fluorkohlenwasserstoffen - Google Patents

Partielle Flüssigkeitsbeatmung mittels Fluorkohlenwasserstoffen

Info

Publication number
DE69227767T2
DE69227767T2 DE69227767T DE69227767T DE69227767T2 DE 69227767 T2 DE69227767 T2 DE 69227767T2 DE 69227767 T DE69227767 T DE 69227767T DE 69227767 T DE69227767 T DE 69227767T DE 69227767 T2 DE69227767 T2 DE 69227767T2
Authority
DE
Germany
Prior art keywords
fluorocarbons
partial liquid
liquid ventilation
breathing
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69227767T
Other languages
English (en)
Other versions
DE69227767D1 (de
Inventor
Nicholas Simon Faithfull
Jeffry Greg Weers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alliance Pharmaceutical Corp
Original Assignee
Alliance Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliance Pharmaceutical Corp filed Critical Alliance Pharmaceutical Corp
Publication of DE69227767D1 publication Critical patent/DE69227767D1/de
Application granted granted Critical
Publication of DE69227767T2 publication Critical patent/DE69227767T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/035—Halogenated hydrocarbons having aliphatic unsaturation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0476—Oxygenated solutions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00—Surgery
    • Y10S128/913—Breathable liquids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Gas Separation By Absorption (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69227767T 1991-05-03 1992-05-01 Partielle Flüssigkeitsbeatmung mittels Fluorkohlenwasserstoffen Expired - Fee Related DE69227767T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69554791A 1991-05-03 1991-05-03
PCT/US1992/003660 WO1992019232A1 (en) 1991-05-03 1992-05-01 Partial liquid breathing of fluorocarbons

Publications (2)

Publication Number Publication Date
DE69227767D1 DE69227767D1 (de) 1999-01-14
DE69227767T2 true DE69227767T2 (de) 1999-04-22

Family

ID=24793466

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69227767T Expired - Fee Related DE69227767T2 (de) 1991-05-03 1992-05-01 Partielle Flüssigkeitsbeatmung mittels Fluorkohlenwasserstoffen

Country Status (11)

Country Link
US (6) US5490498A (de)
EP (2) EP0583358B1 (de)
JP (1) JP2607021B2 (de)
AT (1) ATE173920T1 (de)
AU (1) AU1927192A (de)
CA (1) CA2102321C (de)
DE (1) DE69227767T2 (de)
DK (1) DK0583358T3 (de)
ES (1) ES2124260T3 (de)
HK (1) HK1014149A1 (de)
WO (1) WO1992019232A1 (de)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU704024B2 (en) * 1991-05-01 1999-04-15 University Of Pittsburgh Perfluorocarbon associated gas exchange and partial liquid breathing of fluorocarbons
AU749728B2 (en) * 1991-05-01 2002-07-04 University Of Pittsburgh Perfluorocarbon associated gas exchange and partial liquid breathing of fluorocarbons
ES2124260T3 (es) * 1991-05-03 1999-02-01 Alliance Pharma Respiracion liquida parcial de fluorocarbonos.
US5470885A (en) * 1993-09-29 1995-11-28 The Research Foundation Of The State University Of New York Fluorocarbons as anti-inflammatory agents
US5492109A (en) * 1993-11-03 1996-02-20 The Regents Of The University Of Michigan Liquid ventilator with venturi-inducing patient connector
US5674913A (en) * 1994-05-13 1997-10-07 Synthetic Blood International, Inc. Method for assisting normal breathing in a mammal having a lung disorder
US5824703A (en) * 1994-05-13 1998-10-20 Synthetic Blood International, Inc. Method of assisting normal breathing in a mammal having a lung disorder
US5531219A (en) * 1994-11-04 1996-07-02 Alliance Pharmaceutical Corp. Use of liquid fluorocarbons to facilitate pulmonary drug delivery
US5859068A (en) * 1995-02-24 1999-01-12 Children's Medical Center Corporation Acceleration of tissue growth using fluorocarbon liquid
US6155252A (en) * 1995-03-17 2000-12-05 Board Of Regents, The University Of Texas System Method and apparatus for directing air flow within an intubated patient
US6041777A (en) * 1995-12-01 2000-03-28 Alliance Pharmaceutical Corp. Methods and apparatus for closed-circuit ventilation therapy
US5840767A (en) * 1995-12-01 1998-11-24 Synthetic Blood International, Inc. Perfluorocarbons for biological gas exchange and method
AU713362B2 (en) * 1996-03-08 1999-12-02 Life Resuscitation Technologies, Inc. Liquid ventilation method and apparatus
US5829428A (en) 1996-05-29 1998-11-03 Alliance Pharmaceutical Corp. Methods and apparatus for reducing the loss of respiratory promoters
US20020017295A1 (en) * 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6433040B1 (en) * 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
AU9593598A (en) 1997-10-01 1999-04-23 Alliance Pharmaceutical Corporation Detection of oxygen carriers in exhaled gases
US6167887B1 (en) 1997-11-21 2001-01-02 Synthetic Blood International, Inc. Selected C-10 perfluorinated hydrocarbons for liquid ventilation and artificial blood
US6894079B1 (en) 1998-12-01 2005-05-17 Alexandre T. Rotta Method for reducing free-radical induced injury
US7017573B1 (en) * 1999-07-12 2006-03-28 Capnia, Incorporated Methods and apparatus for relieving headaches, rhinitis and other common ailments
US20060172017A1 (en) * 1999-11-08 2006-08-03 Capnia, Incorporated Methods and apparatus for the enhanced delivery of physiologic agents to tissue surfaces
US20070039615A1 (en) * 1999-11-08 2007-02-22 Capnia, Incorporated Methods and apparatus for treating rhinitis
JP2004500168A (ja) * 1999-11-08 2004-01-08 キャプニア　インコーポレイテッド ガスと薬剤とを共投与して両者の相乗効果で頭痛やアンギナ及び他の症状を軽減するための方法及び装置
AU6124601A (en) 2000-05-10 2001-11-20 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US8404217B2 (en) * 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US20020106368A1 (en) * 2000-07-28 2002-08-08 Adrian Bot Novel methods and compositions to upregulate, redirect or limit immune responses to peptides, proteins and other bioactive compounds and vectors expressing the same
JP2004524933A (ja) * 2001-04-11 2004-08-19 カンドラー ミヒャエル 人工呼吸装置
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
GB2379608A (en) * 2001-09-18 2003-03-19 Kaizen Matsumoto Liquid ventilation for the removal of chemicals
US20030099601A1 (en) * 2001-11-27 2003-05-29 Gordon Marc S. Inhalation lung surfactant therapy
JP2005514393A (ja) * 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
AU2003202237A1 (en) * 2002-01-09 2003-07-30 The Brigham And Women's Hospital, Inc. Method for altering the body temperature of a patient using a nebulized mist
US6743829B2 (en) * 2002-01-18 2004-06-01 Bp Corporation North America Inc. Integrated processing of natural gas into liquid products
US6705316B2 (en) 2002-03-11 2004-03-16 Battelle Pulmonary Therapeutics, Inc. Pulmonary dosing system and method
EP1785156B1 (de) * 2002-08-23 2012-06-27 Schering Corporation Aerosolhaltiger pharmazeutischer Dosierinhalator
US7767232B2 (en) * 2002-09-19 2010-08-03 New York University Control of nitric oxide bioactivity by perfluorocarbons
CA2413041A1 (fr) 2002-11-29 2004-05-29 Jean-Paul Praud Un appareil permettant d'effectuer des ventilations liquides totales
US20040193096A1 (en) * 2003-03-25 2004-09-30 Cooper William Isaac Conceptus chamber
BRPI0418589A (pt) * 2003-12-08 2008-01-29 Bentley Pharmaceuticals Inc composições farmacêuticas e métodos para tratamento por insulina
US20050152844A1 (en) * 2004-01-09 2005-07-14 Barbut Denise R. Transpulmonary systemic cooling using liquid mists
US20050154430A1 (en) * 2004-01-09 2005-07-14 Benecool, Inc. Transpulmonary systemic cooling using liquid mists
US20080019926A1 (en) * 2004-04-19 2008-01-24 Marie-Pierre Krafft Lung Surfactant Supplements
JP2007537833A (ja) * 2004-05-20 2007-12-27 ディスカバリー ラボラトリーズ，インコーポレイテッド 非侵襲的な肺吸入のための方法、システム、及び装置
US8028697B2 (en) 2005-04-28 2011-10-04 Trudell Medical International Ventilator circuit and method for the use thereof
US7909031B2 (en) * 2005-06-09 2011-03-22 Temple Univesity - Of The Commonwealth System of Higher Education Process for transient and steady state delivery of biological agents to the lung via breathable liquids
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
US7371714B2 (en) * 2005-06-23 2008-05-13 The United States Of America As Represented By The Secretary Of The Army Chemical agent decontamination composition comprising a perfluorinated alkyl bromide
DK1962869T3 (da) * 2005-12-21 2013-06-24 Solaeromed Inc Behandling af luftvejssygdomme
US7909033B2 (en) 2006-05-03 2011-03-22 Comedica Incorporated Breathing treatment apparatus
WO2007134304A1 (en) * 2006-05-15 2007-11-22 Virginia Commonwealth University Methods and compositions for controlled and sustained production and delivery of peroxides
US8051854B2 (en) 2006-09-15 2011-11-08 Comedica Incorporated Continuous high-frequency oscillation breathing treatment apparatus
US9050434B2 (en) 2007-05-18 2015-06-09 Comedica Incorporated Lung therapy device
US20090202617A1 (en) * 2008-02-13 2009-08-13 Ward Kevin R Gas based wound and tissue therapeutics
HUE028653T2 (en) 2008-03-17 2016-12-28 Discovery Lab Inc Respiratory circuit adapter and direct aerosol delivery system
US8251876B2 (en) * 2008-04-22 2012-08-28 Hill-Rom Services, Inc. Breathing exercise apparatus
CA2729597C (en) 2008-07-18 2018-01-16 Oxygen Biotherapeutics, Inc. Method of treating traumatic brain injury
EP2626098B1 (de) 2008-10-22 2020-08-19 Trudell Medical International Modulares Aerosolabgabesystem
US8343515B2 (en) 2008-11-25 2013-01-01 Oxygen Biotherapeutics, Inc. Perfluorocarbon gel formulations
US20100144597A1 (en) * 2008-12-10 2010-06-10 Ward Kevin R Novel combinatorial approaches to enhancing oxygen transport to tissues
WO2011014247A1 (en) * 2009-07-28 2011-02-03 Oxygen Biotherapeutics, Inc. Method to increase oxygen in male and female sexual organs through the topical use of perfluorocarbons
US9151425B2 (en) 2009-11-02 2015-10-06 Comedica Incorporated Multiple conduit connector apparatus and method
US8376421B2 (en) * 2010-02-08 2013-02-19 Nationwide Industries, Inc. Magnetic gate latch device
US9351943B2 (en) * 2010-07-01 2016-05-31 Matthew T. McLeay Anti-fibroblastic fluorochemical emulsion therapies
WO2012044963A2 (en) 2010-10-01 2012-04-05 Oxygen Biotherapeutics, Inc. Perfluorocarbons for use in treating pruritus
US9439804B2 (en) * 2011-03-03 2016-09-13 Renaud Tissier Method and system for treatment of a body of a mammal in cardiac arrest
US9180271B2 (en) 2012-03-05 2015-11-10 Hill-Rom Services Pte. Ltd. Respiratory therapy device having standard and oscillatory PEP with nebulizer
US9795752B2 (en) 2012-12-03 2017-10-24 Mhs Care-Innovation, Llc Combination respiratory therapy device, system, and method
WO2016191700A1 (en) * 2015-05-27 2016-12-01 Nuvox Pharma Llc Treatment of acute complications of sickle cell disease
US10046126B2 (en) * 2016-04-27 2018-08-14 Suspended Animation, Inc. Apparatus and method for delivering fluids and/or gases to the lungs
US10662686B2 (en) 2016-09-30 2020-05-26 Barrette Outdoor Living, Inc. Magnetic safety gate latch
WO2018140425A1 (en) * 2017-01-24 2018-08-02 Nuvox Pharma Llc Iso-osmotic and near iso-osmotic oxygen therapeutic formulations and methods thereof
MX2020005403A (es) 2017-10-06 2020-10-28 Sime Diagnostics Ltd Prueba de madurez de pulmón fetal.
WO2020223315A1 (en) * 2019-04-29 2020-11-05 The Children's Hospital Of Philadelphia Liquid ventilation for bronchopulmonary dysplasia
WO2021245239A1 (en) * 2020-06-04 2021-12-09 Sime Diagnostics Ltd. Methods and systems for predicting ards

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975512A (en) * 1970-12-21 1976-08-17 University Of Illinois Foundation Non-toxic brominated perfluorocarbons radiopaque agents
DE2245299A1 (de) * 1971-10-01 1973-04-26 Allied Chem Fluessiges spuelmittel zur spuelung des atemsystems von saeugetieren
SU858824A1 (ru) * 1979-03-22 1981-08-30 Предприятие П/Я Р-6476 Аппарат жидкостного дыхани
SU1143420A1 (ru) * 1983-03-28 1985-03-07 Предприятие П/Я Р-6476 Аппарат дл длительного промывани легких
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
US5562608A (en) * 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
JP2935519B2 (ja) * 1989-08-28 1999-08-16 シーキンス，ケイ・マイケル 超音波および／またはペルフルオロカーボン液での対流を介する肺癌高熱治療
IT1232244B (it) * 1989-09-25 1992-01-28 Sicor Spa Procedimento per la preparazione di beclometasone dipropionato di particolare forma cristallina, adatto per uso negli aerosol dosati microcristallini a base di clorofluorocarburi
US5437272A (en) * 1991-05-01 1995-08-01 Alliance Pharmaceutical Corp. Perfluorocarbon associated gas exchange
ES2124260T3 (es) * 1991-05-03 1999-02-01 Alliance Pharma Respiracion liquida parcial de fluorocarbonos.
US5470885A (en) * 1993-09-29 1995-11-28 The Research Foundation Of The State University Of New York Fluorocarbons as anti-inflammatory agents
US5531219A (en) * 1994-11-04 1996-07-02 Alliance Pharmaceutical Corp. Use of liquid fluorocarbons to facilitate pulmonary drug delivery
US5590651A (en) * 1995-01-17 1997-01-07 Temple University - Of The Commonwealth System Of Higher Education Breathable liquid elimination analysis
US5859068A (en) * 1995-02-24 1999-01-12 Children's Medical Center Corporation Acceleration of tissue growth using fluorocarbon liquid
US6012453A (en) * 1995-04-20 2000-01-11 Figgie Inernational Inc. Apparatus for withdrawal of liquid from a container and method
US6041777A (en) * 1995-12-01 2000-03-28 Alliance Pharmaceutical Corp. Methods and apparatus for closed-circuit ventilation therapy
AU713362B2 (en) * 1996-03-08 1999-12-02 Life Resuscitation Technologies, Inc. Liquid ventilation method and apparatus
US5706830A (en) * 1996-05-06 1998-01-13 South Alabama Medical Science Foundation Liquid ventilator system and use thereof
US5829428A (en) * 1996-05-29 1998-11-03 Alliance Pharmaceutical Corp. Methods and apparatus for reducing the loss of respiratory promoters
SE507617C2 (sv) * 1996-12-20 1998-06-29 Siemens Elema Ab Anordning avsedd att användas vid ett behandlingssystem för respiratorvård med vätska
US6105572A (en) * 1997-11-07 2000-08-22 Alliance Pharmaceutical Corp. Liquid ventilator

Also Published As

Publication number Publication date
DE69227767D1 (de) 1999-01-14
US6119687A (en) 2000-09-19
JP2607021B2 (ja) 1997-05-07
US5853003A (en) 1998-12-29
US5655521A (en) 1997-08-12
EP0583358B1 (de) 1998-12-02
CA2102321C (en) 1999-11-09
WO1992019232A1 (en) 1992-11-12
DK0583358T3 (da) 1999-08-16
EP0908178A1 (de) 1999-04-14
ES2124260T3 (es) 1999-02-01
US6289892B1 (en) 2001-09-18
JPH06507636A (ja) 1994-09-01
US5490498A (en) 1996-02-13
US20030056788A1 (en) 2003-03-27
ATE173920T1 (de) 1998-12-15
CA2102321A1 (en) 1992-12-01
EP0583358A1 (de) 1994-02-23
HK1014149A1 (en) 1999-09-24
AU1927192A (en) 1992-12-21

Similar Documents

Publication Publication Date Title
DE69227767D1 (de) Partielle Flüssigkeitsbeatmung mittels Fluorkohlenwasserstoffen
KR930017471A (ko) 방사선 영상화 방법
EE03221B1 (et) Inhaleeritavad ravimpreparaadid, nende valmistamise protsess ja inhalaator nende kasutamiseks
MX9700034A (es) Formulacion para la aplicacion por inhalacion.
TR200002692T2 (tr) Aerosol haline getirilen aktif maddenin verilmesi.
EA200100338A1 (ru) Способ и устройство для введения действующего вещества в виде аэрозоли в легкие пациента
DE69005951D1 (de) Medikamente enthaltend Salmeterol und Fluticason.
EP0458894A4 (de) Lipidhilfstoffe für verabreichung durch die nase und örtliche anwendung.
ATE135201T1 (de) Mischung aus xenon, sauerstoff und helium zur anästhesie
BR0213397A (pt) Método para suprimento de uma mistura de gases a um paciente, sistema para suprimento de gás a um paciente, usos de halotano, de enflurano, de isoflurano, de sevoflurano e de desflurano no sistema para suprimento, sistema para suprimento de medicamento, e, método para suprimento de medicamento terapêutico
DE3783465T2 (de) Vorrichtung zur abgabe eines definierten atemgas-volumens.
DK0772452T3 (da) Farmaceutisk formulering til subkutan, intramuskulær eller intradermal administration af faktor VIII
ATE216575T1 (de) Treibgasmischung für eine aerosolzubereitung
HUP0102616A1 (hu) Inhalációs készülék és eljárás
HUP0101293A2 (hu) AspB28-humán inzulint tartalmazó inhalációs gyógyászati készítmény és alkalmazása
AR009370A1 (es) UNA COMPOSICION FARMACEUTICA EN AEROSOL ADECUADA PARA LA ADMINISTRACION DE BUDESONIDA, UN PRODUCTO FARMACEUTICO QUE LA CONTIENE, UN METODO PARAADMINISTRAR BUDESONIDA Y USO DE UNA MEZCLA DE HFA 134a Y HFA 227
BR0306282A (pt) Sistema de ventilação em aparelho respiratório
ATE221778T1 (de) Verbindunngen und zusammensetzungen zur verabreichung via inhalation und insufflierung
ATE343407T1 (de) Atemvorrichtung mit einem vernebler
NZ510101A (en) The use of a gas mixture comprising oxygen, carbon dioxide and helium for imagining tumours
ATE259225T1 (de) Anästhetische analgesicte gasmischungen,die enfluran oder isofluran in kombination mit sevofluran oder desfluran enthalten
Schrading et al. Effect of scavenging on ambient levels of nitrous oxide in ambulances
Rosenberg Anesthetic gases as possible hazard to reproduction.
TH16088A (th) สูตรผสมสำหรับการสูดดม

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee